BioInfra Co (199730.KQ) Stock Price

BioInfra Co Price

CLOSED
1,141.00
​
Market closed

Revenue has compounded at 3.4% per year over the past 5 years to 23.15 B KRW. Earnings per share have declined at 21.8% per year over the last 3 years. BioInfra Co's net margin stands at -39.4%, down from 20.4% several years earlier. BioInfra Co currently offers a dividend yield of about 0.35%. The payout ratio is around 1% of earnings.

BioInfra Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioInfra Co business model & stock analysis

BioInfra Co Ltd, based in Yongin, South Korea, operates in the Health Care sector, specifically within Life Sciences Tools & Services. The company focuses on research and development of medicines, chemical substances, and medical devices, alongside conducting drug development, non-clinical and clinical trials, and producing health functional foods. Listed on March 2, 2023, BioInfra employs 113 full-time staff.

Frequently asked questions about BioInfra Co

Converted at the current exchange rate, the BioInfra Co share trades at 0.76 EUR (1,141.00 KRW).

The revenue cannot currently be calculated for BioInfra Co.

The profit cannot currently be calculated for BioInfra Co.

The P/E ratio cannot be calculated for BioInfra Co at the moment.

The P/S cannot be calculated for BioInfra Co currently.

The Eulerpool Quality Score for BioInfra Co is 2/10.

The ISIN of BioInfra Co is KR7199730003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of BioInfra Co is 199730.KQ. The ticker symbol is used to trade BioInfra Co shares on the stock exchange.

Fair ValueTerminal
1,175.23 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
204.85 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
South Korea
Currency
KRW
Initial public offering
Mar 2, 2023
ISIN
KR7199730003
Cusip
Y0R0NW108
Market capitalization
5.53 B KRWMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.34
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-55.37 %
Dividend
Dividend yield
0.35 %
Payout Ratio
1.44 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Nov 10, 2026, 3:48 AM

BioInfra Co Peer Group

BioInfra Co FIGI

199730:KS · BBG00K84FZS4199730:KQ · BBG01B6YDSC4

All fundamentals and in-depth analysis of BioInfra Co

Our stock analysis for BioInfra Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioInfra Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.